Tuberculosis Diagnostics Market By Test Type - Global Industry Analysis And Forecast To 2027

Published On : November 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC111737

SEGMENTS & REGIONS:

Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Report Description
Table of Content

Tuberculosis Diagnostics Market By Test Type (Detection of Drug Resistance, Radiographic Method, Cytokine Detection Assay, Diagnostic Laboratory Methods, Nucleic Acid Testing, Detection of Latent Infection and Phage Assay) - Global Industry Analysis And Forecast To 2027

Industry Outlook

The disorder of tuberculosis is analyzed by discovering the bacteria named Mycobacterium tuberculosis microscopic in the clinical samples taken from the people suffering from this disorder. While different examinations may firmly propose tuberculosis as the finding, they can't affirm it. The total therapeutic assessment for the tuberculosis (TB) must incorporate the medicinal history, the physical examination, the microbiological examination and the chest X-ray (of the sputum or some other proper specimen). It might likewise incorporate the tuberculin skin test, X-rays, surgical biopsy and other medical scan tests. Therefore, the Tuberculosis Diagnostics Market is anticipated to expand and has tremendous scope during the forecast period. The global Tuberculosis Diagnostics Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

On the basis of Test Type the market is segmented into Detection of Drug Resistance, Radiographic Method, Cytokine Detection Assay, Diagnostic Laboratory Methods, Nucleic Acid Testing, Detection of Latent Infection and Phage Assay. The Diagnostic Laboratory Methods rising number of cases related to TB, the method like culture-based tests & smear microscopy, etc.

Regional Insights

The Asia Pacific region is leading the global Tuberculosis Diagnostics Market owing to rising number of cases of this disorder, and other factors.

Tuberculosis Diagnostics Market, By Region

- North America
U.S.
Canada
Mexico
- Europe
Germany
UK
France
Russia
Italy
Rest of Europe
- Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
- South America
Brazil
Argentina
Columbia
Rest of South America
- Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

QIAGEN
Thermo Fisher Scientific Inc.
Hain Lifescience GmbH
bioMerieux SA
Hologic Corporation
Abbott Laboratories
Cepheid
Alere Inc.
Becton
Sanofi
Dickinson and Company
F. Hoffmann-La Roche AG

Some of the key questions answered by the report are:

What was the market size in 2017 and forecast from 2017 to 2027?
What will be the industry market growth from 2017 to 2027?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o Tuberculosis Diagnostics Market, By Test Type, Estimates and Forecast, 2017-2027 ($Million)

o Detection of Drug Resistance

o Radiographic Method

o Cytokine Detection Assay

o Diagnostic Laboratory Methods

o Nucleic Acid Testing

o Detection of Latent Infection

o Phage Assay

o Tuberculosis Diagnostics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o North America

§ North America Tuberculosis Diagnostics Market, By Country

o U.S. Tuberculosis Diagnostics Market

o Canada Tuberculosis Diagnostics Market

o Mexico Tuberculosis Diagnostics Market

o Europe

§ Europe Tuberculosis Diagnostics Market, By Country

o Germany Tuberculosis Diagnostics Market

o UK Tuberculosis Diagnostics Market

o France Tuberculosis Diagnostics Market

o Russia Tuberculosis Diagnostics Market

o Italy Tuberculosis Diagnostics Market

o Rest of Europe Tuberculosis Diagnostics Market

o Asia-Pacific

§ Asia-Pacific Tuberculosis Diagnostics Market, By Country

o China Tuberculosis Diagnostics Market

o Japan Tuberculosis Diagnostics Market

o South Korea Tuberculosis Diagnostics Market

o India Tuberculosis Diagnostics Market

o Southeast Asia Tuberculosis Diagnostics Market

o Rest of Asia-Pacific Tuberculosis Diagnostics Market

o South America

§ South America Tuberculosis Diagnostics Market, By Country

o Brazil Tuberculosis Diagnostics Market

o Argentina Tuberculosis Diagnostics Market

o Columbia Tuberculosis Diagnostics Market

o Rest of South America Tuberculosis Diagnostics Market

o Middle East and Africa

§ Middle East and Africa Tuberculosis Diagnostics Market, By Country

o Saudi Arabia Tuberculosis Diagnostics Market

o UAE Tuberculosis Diagnostics Market

o Egypt Tuberculosis Diagnostics Market

o Nigeria Tuberculosis Diagnostics Market

o South Africa Tuberculosis Diagnostics Market

o Rest of MEA Tuberculosis Diagnostics Market

Table of Contents:

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. SWOT Analysis

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market Status and Outlook (2017-2027)

4.1.2. Canada Market Status and Outlook (2017-2027)

4.1.3. Mexico Market Status and Outlook (2017-2027)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market Status and Outlook (2017-2027)

4.2.2. France Market Status and Outlook (2017-2027)

4.2.3. UK Market Status and Outlook (2017-2027)

4.2.4. Russia Market Status and Outlook (2017-2027)

4.2.5. Italy Market Status and Outlook (2017-2027)

4.2.6. Rest of Europe Market Status and Outlook (2017-2027)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market Status and Outlook (2017-2027)

4.3.2. Japan Market Status and Outlook (2017-2027)

4.3.3. Korea Market Status and Outlook (2017-2027)

4.3.4. India Market Status and Outlook (2017-2027)

4.3.5. Southeast Asia Market Status and Outlook (2017-2027)

4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market Status and Outlook (2017-2027)

4.4.2. Argentina Market Status and Outlook (2017-2027)

4.4.3. Columbia Market Status and Outlook (2017-2027)

4.4.4. Rest of South America Market Status and Outlook (2017-2027)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3. Egypt Market Status and Outlook (2017-2027)

4.5.4. Nigeria Market Status and Outlook (2017-2027)

4.5.5. South Africa Market Status and Outlook (2017-2027)

4.5.6. Turkey Market Status and Outlook (2017-2027)

4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5. Tuberculosis Diagnostics Market, By Test Type

5.1. Introduction

5.2. Global Tuberculosis Diagnostics Revenue and Market Share by Test Type (2017-2027)

5.2.1. Global Tuberculosis Diagnostics Revenue and Revenue Share by Test Type (2017-2027)

5.3. Detection of Drug Resistance

5.3.1. Global Detection of Drug Resistance Revenue and Growth Rate (2017-2027)

5.4. Radiographic Method

5.4.1. Global Radiographic Method Revenue and Growth Rate (2017-2027)

5.5. Cytokine Detection Assay

5.5.1. Global Cytokine Detection Assay Revenue and Growth Rate (2017-2027)

5.6. Diagnostic Laboratory Methods

5.6.1. Global Diagnostic Laboratory Methods Revenue and Growth Rate (2017-2027)

5.7. Nucleic Acid Testing

5.7.1. Global Nucleic Acid Testing Revenue and Growth Rate (2017-2027)

5.8. Detection of Latent Infection

5.8.1. Global Detection of Latent Infection Revenue and Growth Rate (2017-2027)

5.9. Phage Assay

5.9.1. Global Phage Assay Revenue and Growth Rate (2017-2027)

6. Tuberculosis Diagnostics Market, By Region

6.1. Introduction

6.2. Global Tuberculosis Diagnostics Revenue and Market Share by Regions

6.2.1. Global Tuberculosis Diagnostics Revenue by Regions (2017-2027)

6.3. North America Tuberculosis Diagnostics by Countries

6.3.1. North America Tuberculosis Diagnostics Revenue and Growth Rate (2017-2027)

6.3.2. North America Tuberculosis Diagnostics Revenue (Million USD) by Countries (2017-2027)

6.3.3. United States

6.3.3.1. United States Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.4. Canada

6.3.4.1. Canada Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.5. Mexico

6.3.5.1. Mexico Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.4. Europe Tuberculosis Diagnostics by Countries

6.4.1. Europe Tuberculosis Diagnostics Revenue and Growth Rate (2017-2027)

6.4.2. Europe Tuberculosis Diagnostics Revenue (Million USD) by Countries (2017-2027)

6.4.3. Germany

6.4.3.1. Germany Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.4. France

6.4.4.1. France Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.5. UK

6.4.5.1. UK Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.6. Russia

6.4.6.1. Russia Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.7. Italy

6.4.7.1. Italy Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.8. Rest of Europe

6.4.8.1. Rest of Europe Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.5. Asia-Pacific Tuberculosis Diagnostics by Countries

6.5.1. Asia-Pacific Tuberculosis Diagnostics Revenue and Growth Rate (2017-2027)

6.5.2. Asia-Pacific Tuberculosis Diagnostics Revenue (Million USD) by Countries (2017-2027)

6.5.3. China

6.5.3.1. China Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.4. Japan

6.5.4.1. Japan Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.5. Korea

6.5.5.1. Korea Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.6. India

6.5.6.1. India Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.7. Southeast Asia

6.5.7.1. Southeast Asia Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.8. Rest of Asia-Pacific

6.5.8.1. Rest of Asia-Pacific Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.6. South America Tuberculosis Diagnostics by Countries

6.6.1. South America Tuberculosis Diagnostics Revenue and Growth Rate (2017-2027)

6.6.2. South America Tuberculosis Diagnostics Revenue (Million USD) by Countries (2017-2027)

6.6.3. Brazil

6.6.3.1. Brazil Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.4. Argentina

6.6.4.1. Argentina Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.5. Columbia

6.6.5.1. Columbia Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.6. Rest of South America

6.6.6.1. Rest of South America Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.7. Middle East and Africa Tuberculosis Diagnostics by Countries

6.7.1. Middle East and Africa Tuberculosis Diagnostics Revenue and Growth Rate (2017-2027)

6.7.2. Middle East and Africa Tuberculosis Diagnostics Revenue (Million USD) by Countries (2017-2027)

6.7.3. Saudi Arabia

6.7.3.1. Saudi Arabia Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.4. United Arab Emirates

6.7.4.1. United Arab Emirates Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.5. Egypt

6.7.5.1. Egypt Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.6. Nigeria

6.7.6.1. Nigeria Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.7. South Africa

6.7.7.1. South Africa Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.8. Turkey

6.7.8.1. Turkey Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.9. Rest of Middle East and Africa

6.7.9.1. Rest of Middle East and Africa Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

7. Company Profiles

7.1. QIAGEN

7.1.1. Business Overview

7.1.2. Service Portfolio

7.1.3. Strategic Developments

7.1.4. Revenue and Market Share

7.2. Thermo Fisher Scientific Inc.

7.2.1. Business Overview

7.2.2. Service Portfolio

7.2.3. Strategic Developments

7.2.4. Revenue and Market Share

7.3. Hain Lifescience GmbH

7.3.1. Business Overview

7.3.2. Service Portfolio

7.3.3. Strategic Developments

7.3.4. Revenue and Market Share

7.4. bioMerieux SA

7.4.1. Business Overview

7.4.2. Service Portfolio

7.4.3. Strategic Developments

7.4.4. Revenue and Market Share

7.5. Hologic Corporation

7.5.1. Business Overview

7.5.2. Service Portfolio

7.5.3. Strategic Developments

7.5.4. Revenue and Market Share

7.6. Abbott Laboratories

7.6.1. Business Overview

7.6.2. Service Portfolio

7.6.3. Strategic Developments

7.6.4. Revenue and Market Share

7.7. Cepheid

7.7.1. Business Overview

7.7.2. Service Portfolio

7.7.3. Strategic Developments

7.7.4. Revenue and Market Share

7.8. Alere Inc.

7.8.1. Business Overview

7.8.2. Service Portfolio

7.8.3. Strategic Developments

7.8.4. Revenue and Market Share

7.9. Becton

7.9.1. Business Overview

7.9.2. Service Portfolio

7.9.3. Strategic Developments

7.9.4. Revenue and Market Share

7.10. Sanofi

7.10.1. Business Overview

7.10.2. Service Portfolio

7.10.3. Strategic Developments

7.10.4. Revenue and Market Share

7.11. Dickinson and Company

7.11.1. Business Overview

7.11.2. Service Portfolio

7.11.3. Strategic Developments

7.11.4. Revenue and Market Share

7.12. F. Hoffmann-La Roche AG

7.12.1. Business Overview

7.12.2. Service Portfolio

7.12.3. Strategic Developments

7.12.4. Revenue and Market Share

8. Global Tuberculosis Diagnostics Market Competition, by Manufacturer

8.1. Global Tuberculosis Diagnostics Revenue and Market Share by Manufacturer (2017-2017)

8.2. Global Tuberculosis Diagnostics Price By Region (2017-2017)

8.3. Top 5 Tuberculosis Diagnostics Manufacturer Market Share

8.4. Market Competition Trend

9. Tuberculosis Diagnostics Market Forecast (2017-2027)

9.1. Global Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)

9.2. Tuberculosis Diagnostics Market Forecast by Regions (2017-2027)

9.2.1. North America Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.1.1. United States Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.1.2. Canada Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.1.3. Mexico Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.2. Europe Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.2.1. Germany Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.2.2. France Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.2.3. UK Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.2.4. Russia Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.2.5. Italy Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.2.6. Rest of Europe Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.3. Asia-Pacific Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.3.1. China Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.3.2. Japan Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.3.3. Korea Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.3.4. India Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.3.5. Southeast Asia Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.3.6. Rest of Asia-Pacific Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.4. South America Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.4.1. Brazil Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.4.2. Argentina Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.4.3. Columbia Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.4.4. Rest of South America Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.5. Middle East and Africa Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.5.1. Saudi Arabia Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.5.2. United Arab Emirates Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.5.3. Egypt Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.5.4. Nigeria Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.5.5. South Africa Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.5.6. Turkey Tuberculosis Diagnostics Market Forecast (2017-2027)

9.2.5.7. Rest of Middle East and Africa Tuberculosis Diagnostics Market Forecast (2017-2027)

9.3. Tuberculosis Diagnostics Market Forecast by Test Type (2017-2027)

9.3.1. Tuberculosis Diagnostics Forecast by Test Type (2017-2027)

9.3.2. Tuberculosis Diagnostics Market Share Forecast by Test Type (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Tuberculosis Diagnostics Revenue and Revenue Share by Test Type (2017-2018)
Figure Global Detection of Drug Resistance Revenue and Growth Rate (2017-2018)
Figure Global Radiographic Method Revenue and Growth Rate (2017-2018)
Figure Global Cytokine Detection Assay Revenue and Growth Rate (2017-2018)
Figure Global Diagnostic Laboratory Methods Revenue and Growth Rate (2017-2018)
Figure Global Nucleic Acid Testing Revenue and Growth Rate (2017-2018)
Figure Global Detection of Latent Infection Revenue and Growth Rate (2017-2018)
Figure Global Phage Assay Revenue and Growth Rate (2017-2018)
Table Global Tuberculosis Diagnostics Revenue by Regions (2017-2018)
Figure North America Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure North America Tuberculosis Diagnostics Revenue and Growth Rate (2017-2018)
Figure North America Tuberculosis Diagnostics by Countries (2017-2018)
Figure North America Tuberculosis Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure United States Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure United States Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Canada Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Mexico Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Europe Tuberculosis Diagnostics Revenue and Growth Rate (2017-2018)
Figure Europe Tuberculosis Diagnostics by Countries (2017-2018)
Figure Europe Tuberculosis Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Germany Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure France Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure UK Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Russia Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Italy Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Rest of Europe Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Asia-Pacific Tuberculosis Diagnostics Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Tuberculosis Diagnostics by Countries (2017-2018)
Figure Asia-Pacific Tuberculosis Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure China Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure China Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Japan Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Korea Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure India Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Southeast Asia Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure South America Tuberculosis Diagnostics Revenue and Growth Rate (2017-2018)
Figure South America Tuberculosis Diagnostics by Countries (2017-2018)
Figure South America Tuberculosis Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Brazil Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Argentina Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Columbia Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Rest of South America Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Middle East and Africa Tuberculosis Diagnostics Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Tuberculosis Diagnostics by Countries (2017-2018)
Figure Middle East and Africa Tuberculosis Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Saudi Arabia Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure United Arab Emirates Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Egypt Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Nigeria Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure South Africa Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Turkey Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Tuberculosis Diagnostics Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Table QIAGEN Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Thermo Fisher Scientific Inc. Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Hain Lifescience GmbH Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table bioMerieux SA Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Hologic Corporation Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cepheid Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Alere Inc. Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Becton Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Dickinson and Company Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table F. Hoffmann-La Roche AG Tuberculosis Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Tuberculosis Diagnostics Market Share by Manufacturer
Figure Global Tuberculosis Diagnostics Revenue and Market Share by Manufacturer
Table Global Tuberculosis Diagnostics Price by Region (2017-2017)
Figure Top 5 Tuberculosis Diagnostics Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Tuberculosis Diagnostics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Tuberculosis Diagnostics Market Forecast by Regions (2018-2025)
Figure North America Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure United States Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Canada Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Mexico Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Europe Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Germany Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure France Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure UK Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Russia Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Italy Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Rest of Europe Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Asia-Pacific Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure China Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Japan Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Korea Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure India Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Southeast Asia Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure South America Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Brazil Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Argentina Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Columbia Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Rest of South America Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Middle East and Africa Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Saudi Arabia Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure United Arab Emirates Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Egypt Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Nigeria Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure South Africa Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Turkey Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Tuberculosis Diagnostics Market Forecast (2018-2025)
Figure Global Tuberculosis Diagnostics Forecast by Test Type (2018-2025)
Figure Global Tuberculosis Diagnostics Market Share Forecast by Test Type (2018-2025)
Figure Global Tuberculosis Diagnostics Forecast by Test Type (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

Number of patients for particular device or medical procedure and
Repeated use of particular device depending on health and condition of patient

Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample

Requirement/Comment